Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review

Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review

Although B-type Natriuretic Peptide (BNP), N-terminal-proBNP (NT-proBNP), and mid-regional-proANP (MR-proANP) are included in current guidelines on heart failure in adults, no guideline considering these biomarkers in pediatric heart failure is available. A new drug class of neprilysin inhibitors as...

Full description

Bibliographic Details
Main Authors: Tanja Gangnus, Bjoern B. Burckhardt
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Pediatrics
Subjects:
pediatric
natriuretic peptide
heart failure
ANP
BNP
sacubitril
Online Access:https://www.frontiersin.org/article/10.3389/fped.2018.00420/full

Similar Items

Similar Items